We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Inventiva | TG:6IV | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|
-0.02 | -0.89% | 2.23 | 50 | 22:50:07 |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
2.21 | 2.25 | 2.25 | 2.25 | 2.25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
- |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
12:43:33 | 50 | 2.25 | EUR |
Date | Time | Source | Headline |
---|---|---|---|
10/2/2025 | 21:00 | UKREG | Inventiva publie ses résultats financiers préliminaires pour l'exercice.. |
10/2/2025 | 21:00 | UKREG | Inventiva reports preliminary 2024 fiscal year financial results¹ and.. |
29/1/2025 | 21:00 | UKREG | Inventiva announces the publication of the results from the.. |
29/1/2025 | 21:00 | UKREG | Inventiva annonce la publication dans la revue « Journal of Hepatology ».. |
24/1/2025 | 21:00 | UKREG | Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux |
24/1/2025 | 21:00 | UKREG | Bilan semestriel du contrat de liquidité de la société Inventiva conclu.. |
22/1/2025 | 21:00 | UKREG | Résultats de LEGEND évaluant la combinaison de lanifibranor avec.. |
22/1/2025 | 21:00 | UKREG | Results of LEGEND evaluating lanifibranor in combination with empagliflozin.. |
17/12/2024 | 21:00 | UKREG | Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference |
17/12/2024 | 21:00 | UKREG | Inventiva annonce sa participation à la « 43rd Annual J.P. Morgan.. |
Inventiva (6IV) Share Charts1 Year Inventiva Chart |
|
1 Month Inventiva Chart |
Intraday Inventiva Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions